Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism

323Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Massive pulmonary embolism was confirmed by pulmonary arteriography in 23 patients. All were seen between 2 and 48 hours after the onset of embolism and none had pre-existing cardiorespiratory disease. Fifteen were treated with streptokinase and eight with heparin. Factors which might influence prognosis and rate of resolution were similar in the patients in each group, and there was no significant difference between the groups in terms of pretreatment haemodynamic or arteriographic findings. Haemodynamic and arterio-graphic findings after treatment for 72 hours provided an objective measurement of resolution, which was significantly greater in the streptokinase-treated patients. There was no mortality in either group, but treatment had to be changed in two heparin-treated patients because of clinical deterioration. The principal complication of treatment, seen more often in the streptokinase-treated patients, was bleeding from cut-down or operation sites. © 1971, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Miller, G. A. H., Sutton, G. C., Kerr, I. H., Gibson, R. V., & Honey, M. (1971). Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism. British Medical Journal, 2(5763), 681–684. https://doi.org/10.1136/bmj.2.5763.681

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free